Back
Keros Therapeutics Stock Price Chart
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Buy
80
KROS
Keros Therapeutics
Last Price:
64.84
Seasonality Move:
23.73%
7 Day Trial
ALL ACCESS PASS
$
7
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade- The current trend is moderately bullish and KROS is experiencing selling pressure, which indicates risk of future bearish movement.
Keros Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 63.78 | Buy |
| 20-day SMA: | 61.65 | Buy |
| 50-day SMA: | 58.33 | Buy |
| 200-day SMA: | 55.31 | Buy |
| 8-day EMA: | 64.95 | Buy |
| 20-day EMA: | 62.24 | Buy |
| 50-day EMA: | 58.55 | Buy |
| 200-day EMA: | 52.81 | Buy |
Keros Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.39 | Buy |
| Relative Strength Index (14 RSI): | 73.02 | Buy |
| Chaikin Money Flow: | -329831 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (58.14 - 64.12) | Buy |
| Bollinger Bands (100): | (45.66 - 59.36) | Buy |
Keros Therapeutics Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Keros Therapeutics Stock
Is Keros Therapeutics Stock a Buy?
- Keros Therapeutics share price is 68.15 while KROS 8-day simple moving average is 63.78, which is a Buy signal.
- The stock price of KROS is 68.15 while Keros Therapeutics 20-day SMA is 61.65, which makes it a Buy.
- Keros Therapeutics 50-day simple moving average is 58.33 while KROS share price is 68.15, making it a Buy technically.
- KROS stock price is 68.15 and Keros Therapeutics 200-day simple moving average is 55.31, creating a Buy signal.
KROS Technical Analysis vs Fundamental Analysis
Buy
80
Keros Therapeutics (KROS)
is a Buy
Is Keros Therapeutics a Buy or a Sell?
-
Keros Therapeutics stock is rated a Buy
The current Keros Therapeutics [KROS] share price is $68.15. The Score for KROS is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
Keros Therapeutics Stock Info
Market Cap:
2.76B
Price in USD:
68.15
Share Volume:
422.54K
Keros Therapeutics 52-Week Range
52-Week High:
73.00
52-Week Low:
27.31
Buy
80
Keros Therapeutics (KROS)
is a Buy
Keros Therapeutics Share Price Forecast
-
What is the Keros Therapeutics stock price today?
The Keros Therapeutics stock price is 68.15 USD today. -
Will KROS stock go up or go down?
Keros Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Keros Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Keros Therapeutics is not overvalued.
Is Keros Therapeutics Stock a Buy?
- Keros Therapeutics share price is 68.15 while KROS 8-day exponential moving average is 64.95, which is a Buy signal.
- The stock price of KROS is 68.15 while Keros Therapeutics 20-day EMA is 62.24, which makes it a Buy.
- Keros Therapeutics 50-day exponential moving average is 58.55 while KROS share price is 68.15, making it a Buy technically.
- KROS stock price is 68.15 and Keros Therapeutics 200-day simple moving average is 52.81, creating a Buy signal.
Fundamental Analysis of Keros Therapeutics
Is Keros Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.09 per share, and a decrease next year of $0.48 per share.
Technical Analysis of Keros Therapeutics
Should I short Keros Therapeutics stock?
- KROS Moving Average Covergence Divergence (MACD) indicator is 2.39, suggesting Keros Therapeutics is a Buy
- Keros Therapeutics Relative Strength Index (RSI) is 73.02, which suggest Keros Therapeutics is overbought
- The Bollinger Bands (25) for Keros Therapeutics is (58.14 - 64.12), which suggest Keros Therapeutics is a Buy
- The Bollinger Bands (100) for Keros Therapeutics is (45.66 - 59.36), which suggest Keros Therapeutics is a Buy
* Keros Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.